Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs”

被引：0

作者：

Federico Spandonaro

Fabio Ayala

Enzo Berardesca

Sergio Chimenti

Giampiero Girolomoni

Patrizia Martini

Andrea Peserico

Barbara Polistena

Antonio Puglisi Guerra

Gino Antonio Vena

Gianfranco Altomare

Piergiacomo Calzavara Pinton

机构：

[1] University of Rome Tor Vergata,Department of Dermatology

[2] University of Naples Federico II,Department of Dermatology

[3] San Gallicano Dermatological Institute,Section of Dermatology and Venereology, Department of Medicine

[4] University of Rome Tor Vergata,Unit of Dermatology

[5] University of Verona,Unit of Dermatology, Department of Medicine

[6] Lucca Hospital,Department of Dermatology

[7] University of Padua,Unit of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology

[8] Messina Hospital,Department of Dermatology

[9] University of Bari,Department of Dermatology

[10] University of Milan,undefined

[11] Spedali Civili,undefined

来源：

BioDrugs | 2015年 / 29卷

关键词：

Psoriasis; Plaque Psoriasis; Social Acceptability; Reimbursement Decision; Chronic Plaque Psoriasis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：71 / 72

页数：1

共 3 条